Schedule 13G ownership disclosure

BICYCLE THERAPEUTICS PLC

Ordinary Shares, nominal value GBP 0.01 per share · CUSIP: 088786108

Event date: 2026-02-25

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Invus Public Equities, L.P.

    Shares: 2,719,707.00 · Class: 5.4%

  • Invus Public Equities Advisors, LLC

    Shares: 2,719,707.00 · Class: 5.4%

  • Invus Global Management, LLC

    Shares: 2,719,707.00 · Class: 5.4%

  • Siren, L.L.C.

    Shares: 2,719,707.00 · Class: 5.4%

  • Avicenna Life Sci Master Fund LP

    Shares: 429,342.00 · Class: 0.9%

  • Avicenna Life Sci Master GP LLC

    Shares: 429,342.00 · Class: 0.9%

  • Ulys, L.L.C.

    Shares: 429,342.00 · Class: 0.9%

  • Raymond Debbane

    Shares: 3,149,049.00 · Class: 6.3%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0002005369-26-000016
Form type
SCHEDULE 13G
Filer
BICYCLE THERAPEUTICS PLC
CIK
CIK 1761612
Filed
Mar 03, 2026
Reporting period
Feb 25, 2026
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub